Clinical trial
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or…
NCT00006225 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00006225 |
|---|---|
| Title | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer |
| Official title | Ex Vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients: A Phase I/II Study |
| Lead sponsor | Northwestern University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic/Myeloproliferative Diseases |
| Intervention type | Biological, Procedure |
| Interventions | filgrastim, recombinant flt3 ligand, recombinant human thrombopoietin, recombinant interleukin-3, in vitro-treated peripheral blood stem cell transplantation |
| Start date | Nov 1, 1999 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | May 7, 2003 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: